Supotran
Supotran Brand names, Supotran Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Supotran Brand Names Mixture
- No information avaliable
Supotran Chemical_Formula
C11H12ClNO3S
Supotran RX_link
No information avaliable
Supotran fda sheet
Supotran msds (material safety sheet)
Supotran Synthesis Reference
No information avaliable
Supotran Molecular Weight
273.737 g/mol
Supotran Melting Point
116.2 oC
Supotran H2O Solubility
2500 mg/L (hardly soluble)
Supotran State
Solid
Supotran LogP
1.208
Supotran Dosage Forms
No information avaliable
Supotran Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Supotran Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Supotran Absorption
No information avaliable
Supotran side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Supotran Patient Information
No information avaliable
Supotran Organisms Affected
Humans and other mammals
